GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipocine Inc (STU:2VT0) » Definitions » Cash Receipts from Loans
中文

Lipocine (STU:2VT0) Cash Receipts from Loans


View and export this data going back to 2016. Start your Free Trial

Cash Receipts from Loans only applicable to companies reporting Cash Flow from Operations in direct method.


Lipocine (STU:2VT0) Business Description

Traded in Other Exchanges
Address
675 Arapeen Drive, Suite 202, Salt Lake City, UT, USA, 84108
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107.